“…The remaining 33 published articles reported on a sample size range of 9-135 participants. Studies were published between the years of 1995-2018, and targeted multiple diagnoses including but not limited to: multiple sclerosis [24-26, 32-34, 51], Parkinson's disease [26,36,49], brain injury [50,58,60], and schizophrenia [35,43,45,52,54,55,57,61]. Only three papers [27][28][29] and one case study [30] were published with AD as the target population, with an additional study targeting mild vascular dementia [31].…”